Diabetic eye diseases projected to increase

Article

According to the National Eye Institute (NEI), 7.7 million people age 40 and older have diabetic retinopathy, and this number is projected to increase to approximately 11 million people by 2030.

Bethesda, MD-According to the National Eye Institute (NEI), 7.7 million people age 40 and older have diabetic retinopathy, and this number is projected to increase to approximately 11 million people by 2030.

Today, diabetes affects more than 29 million people in the United States or over 9 percent of the population. In addition, another 86 million American adults, more than one out of three individuals, have pre-diabetes, a condition that puts people at increased risk for diabetes. All people with diabetes, type 1 and type 2, are at risk for diabetic eye diseases, including cataract, diabetic retinopathy, and glaucoma.

Microscopic diabetes-related eye damage detected with new technique

While all people with diabetes can develop diabetic eye disease, African Americans, American Indians/Alaska Natives, and Hispanics/Latinos with diabetes are at higher risk of losing vision or going blind from it. All people with diabetes should have a dilated eye exam at least once a year to detect vision problems early.

“In fact, with early detection, timely treatment, and appropriate follow-up care, people with diabetic retinopathy can reduce their risk of severe vision loss by 95 percent,” adds Suber Huang, MD, MBA, chair of the Diabetic Eye Disease Subcommittee for the NEI’s National Eye Health Education Program.

Remind your patients that research has shown that when people with diabetes maintain good control of blood sugar, blood pressure, and cholesterol, they can slow the development and progression of diabetic eye disease. In addition to having a comprehensive dilated eye exam at least once a year, people with diabetes should do the following to keep their health on TRACK:

Take your medications. 

Reach and maintain a healthy weight.

Add physical activity to your daily routine.

Control your blood sugar, blood pressure, and cholesterol.

Kick the smoking habit.

Diabetes nation: Addressing an epidemic

Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Dr. Julie Rodman previews her SECO presentations
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
© 2025 MJH Life Sciences

All rights reserved.